These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression. Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075 [TBL] [Abstract][Full Text] [Related]
7. MiR-499 regulates cell proliferation and apoptosis during late-stage cardiac differentiation via Sox6 and cyclin D1. Li X; Wang J; Jia Z; Cui Q; Zhang C; Wang W; Chen P; Ma K; Zhou C PLoS One; 2013; 8(9):e74504. PubMed ID: 24040263 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A. Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809 [TBL] [Abstract][Full Text] [Related]
9. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression. Wang T; Zhai M; Xu S; Ponnusamy M; Huang Y; Liu CY; Wang M; Shan C; Shan PP; Gao XQ; Wang K; Chen XZ; Liu J; Xie JY; Zhang DY; Zhou LY; Wang K Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137 [TBL] [Abstract][Full Text] [Related]
10. miR-380-3p regulates melanogenesis by targeting SOX6 in melanocytes from alpacas (Vicugna pacos). Liu X; Du B; Zhang P; Zhang J; Zhu Z; Liu B; Fan R BMC Genomics; 2019 Dec; 20(1):962. PubMed ID: 31823726 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling. Li G; Shao Y; Guo HC; Zhi Y; Qiao B; Ma K; Du J; Lai YQ; Li Y Cardiovasc Res; 2022 Jul; 118(9):2139-2151. PubMed ID: 34358309 [TBL] [Abstract][Full Text] [Related]
12. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p. Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004 [TBL] [Abstract][Full Text] [Related]
13. Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p. Xu X; Wang J; Wang X Drug Des Devel Ther; 2020; 14():5699-5710. PubMed ID: 33402817 [TBL] [Abstract][Full Text] [Related]
14. MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7. Wang L; Qin D; Shi H; Zhang Y; Li H; Han Q Biomed Res Int; 2019; 2019():1580982. PubMed ID: 31341888 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention. Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036 [TBL] [Abstract][Full Text] [Related]
16. Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy. Diniz GP; Huang ZP; Liu J; Chen J; Ding J; Fonseca RI; Barreto-Chaves ML; Donato J; Hu X; Wang DZ Clin Sci (Lond); 2017 Dec; 131(24):2885-2900. PubMed ID: 29101298 [TBL] [Abstract][Full Text] [Related]